Myeloma CellQuest Grant

Accelerating Progress in Multiple Myeloma Clinical Research

Call for CellQuest Research Grant Proposals

Join us in cutting-edge multiple myeloma clinical research through our exclusive grant opportunity. Multiple myeloma is a complex disorder characterized by abnormal plasma cell growth and bone marrow infiltration. Understanding this challenging disease is crucial for patients and their families, and we recognize the invaluable contribution of MARS® platform users and their innovative research.

We are excited to open this call, empowering researchers to drive scientific breakthroughs that have the potential to revolutionize our understanding of multiple myeloma.

About the Grant

Join us for a prestigious grant opportunity targeting scientists across clinical research disciplines, with a special focus on multiple myeloma and cell therapy development. This grant aims to provide instrumental and reagent support, as well as recognition, to outstanding projects demonstrating the potential to drive breakthroughs in these fields.


Exploring the Microenvironment of Bone Marrow in Multiple Myeloma


Understanding Circulating Tumor Cells in Multiple Myeloma


Improving Protocols for Cell-Based Interventions for Multiple Myeloma


Tailored Approaches for Multiple Myeloma Therapy


The grant award encompasses:

  • six-month placement of the MARS® Bar instrument
  • supply of cell isolation reagents* and consumables
  • comprehensive training
  • application development support
  • ongoing assistance from a dedicated Application Scientist

This exceptional package holds a combined value over $30 000.

*Cell separation reagent kits chosen from Applied Cells’ portfolio with a total value not exceeding $8 000.

Application Guidelines

The grant application process is now open and will close in November 2023.
We encourage passionate researchers from around the globe to submit their proposals for a chance to be a part of this exciting opportunity. Take this opportunity to showcase your innovative ideas and contribute to the advancement of scientific knowledge.

To participate in the program, please follow the steps below:

  • Complete the application form available on the submission page.
  • The application form consists of three main sections:
    • Contact and institution information.
    • Abstract.
      A detailed description of your project (up to 800 words), including its goals, the samples involved, the methods employed, expected results, and the potential impact of your research.
    • Supplementary data: Include any relevant supplementary files that can provide additional context to your application. This may include figures, a list of citations, or PDFs from previous publications. Each file should be accompanied by a brief description (up to 200 words).
  • Please note that only one entry per representative will be considered, and incomplete submissions will not be accepted.
  • Submissions should be made exclusively through the online form and must be received no later than November 15th 2023.
  • Please contact our Applied Cells Grant Program Manager to schedule a meeting to discuss how our technology works, how it could help you to achieve your clinical research goals, our reagents portfolio, or anything else you may need to prepare your application. We are looking forward to supporting you with your grant application.

Apply here

One grant recipient will be selected based on the judging process outlined, and the results will be communicated by email from Applied Cells around mid December 2023. The grant recipient is required to accept their award within six months from the date of the award notification.

Eligibility Criteria

The CellQuest grant program is open to researchers in the clinical space, with priority given to projects aligned with the recommended research areas.

  • DECIPHERING THE DISEASE: Exploring the Microenvironment of Bone Marrow in Multiple Myeloma
  • FOCUSING ON DIAGNOSTICS: Understanding Circulating Tumor Cells in Multiple Myeloma
  • ADVANCING TREATMENT: Tailored Approaches for Multiple Myeloma Therapy
  • IMPROVING CELL THERAPY: improving protocols for cell-based interventions for multiple myeloma


CellQuest Grant Program Guidelines are:

  • Applications must be submitted in English language, with one entry allowed per person.
  • Eligible projects should involve human sample types suitable for processing on the MARS® platform, including peripheral blood and blood products, bone marrow aspirates, cultured cells, tissue, and fresh-frozen solid tumors.
  • Employees and immediate family members of Applied Cells are ineligible to participate in the program.
  • This is an international program, open to researchers of all ages (minors excepted), genders, nationalities, backgrounds, and religions.
  • Incomplete or non-compliant submissions will be rejected.
  • The program is subject to applicable laws and regulations.
  • Participants are responsible for confirming that their participation is permitted by their respective university or organization.

Terms and Conditions

Please read the following terms carefully. By submitting an application, you agree to these terms for yourself and on behalf of your Institution/Company. “You” and “your” shall refer to you personally or your Institution/Company, whichever is applicable. If you do not agree to these terms, then please do not apply to this grant program.

Contact us